Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib
抗 BAFF-R 抗体 VAY-736 在 CLL 中表现出良好的临床前活性并可增强依鲁替尼的疗效
期刊:Blood Advances
影响因子:7.4
doi:10.1182/bloodadvances.2018025684
Emily M McWilliams, Christopher R Lucas, Timothy Chen, Bonnie K Harrington, Ronni Wasmuth, Amanda Campbell, Kerry A Rogers, Carolyn M Cheney, Xiaokui Mo, Leslie A Andritsos, Farrukh T Awan, Jennifer Woyach, William E Carson 3rd, Jonathan Butchar, Susheela Tridandapani, Erin Hertlein, Carlos E Castro
